Category Archives: – Pharma

Federal Court of Appeals Rules that FDA Overstepped by Restricting Ivermectin Use

Posted on April 24, 2024 by admin

September 2, 2023- by Steven E. Greer, MD

Posted in - Generics, - Pharma, CDC, Congress, FDA | Leave a comment

Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market

Posted on April 2, 2024 by admin

The transcript is found here May 19, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, CDC, Congress, FDA, Genetics, Infectious disease, NIH, Oncology | 9 Comments

Steven E. Greer, MD testifies to The Ohio Board of Education opposing Biden’s agenda grooming transgenders: Part 1

Posted on March 12, 2024 by admin

September 20, 2022- by Steven E. Greer

Posted in - Opinion, - Pharma, Pediatrics, Plastic surgery, Psychology Psychiatry | Leave a comment

Steven E. Greer, MD testifies to The Ohio Board of Education opposing Biden’s agenda grooming transgenders: Part 2

Posted on March 12, 2024 by admin

October 12, 2022

Posted in - Opinion, - Pharma, - Policy, Pediatrics, Plastic surgery, Primary care medicine, Psychology Psychiatry | Leave a comment

Steven E Greer, MD debates Jim Cramer and Donny Deutsch over DTC television drug ads

Posted on January 28, 2024 by admin

At the time of this debate on CNBC’s Kudlow and Cramer, in 2004, none of the current regulations

Posted in - Opinion, - Pharma, Congress | Leave a comment

Interview with Hélène Banoun about why mRNA “vaccines” should be regulated as gene therapies

Posted on January 28, 2024 by admin

July 12, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Oncology | Leave a comment

Interview with Leslie Manookian, founder of Health Freedom Defense legal fund fighting mask and vaccine mandates

Posted on January 28, 2024 by admin

October 6, 2023- by Steven E. Greer, MD

Posted in - Pharma, CDC, Congress, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Obstetrics and Gynecology | Leave a comment

How to properly study autism

Posted on January 27, 2024 by admin

Update January 8, 2024-

Posted in - Opinion, - Pharma, - Policy, CDC, FDA, Neurology, Neurosurgery, NIH, Pediatrics, Primary care medicine, Psychology Psychiatry | Leave a comment

Any type of coronavirus vaccine (i.e., gene therapy) that uses the spike-protein will be deadly

Posted on January 22, 2024 by admin

February 20, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, FDA | Leave a comment

Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA

Posted on January 20, 2024 by admin

January 19, 2024- by Steven E. Greer, MD

Posted in - Opinion, - Pharma, CDC, Congress, FDA, Infectious disease | 5 Comments

Interview with drug trials expert Sasha Latypova on how the COVID vaccine approvals were a sham

Posted on January 20, 2024 by admin

July 7, 2023- by Steven E. Greer, MD

Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, FDA, Infectious disease, NIH | Leave a comment

Paxlovid causes rebound COVID 25% of the time

Posted on January 14, 2024 by admin

January 7, 2024- by Steven E. Greer, MD

Posted in - Pharma, CDC, Emergency medicine, Infectious disease | Leave a comment

Book: The Pfizer/Moderna mRNA Vaccine (i.e., gene therapy) Toxicity

Posted on December 27, 2023 by admin

September 1, 2023- by Sucharit Bhakdi, MD et al

Posted in - Biotech, - Pharma, - Reviews, books, devices, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology, Pediatrics | Leave a comment

Ivermectin works as an antiviral against SARS-CoV-2 (COVID-19)

Posted on December 27, 2023 by admin

Update September 4, 2022- A new peer-reviewed study found that regular use of ivermectin reduced the risk of dying from COVID-19 by 92%.

Posted in - Biotech, - Generics, - Pharma, FDA, Infectious disease | Leave a comment

Ivermectin works against COVID in double blind, randomized, controlled trial

Posted on December 27, 2023 by admin

May 2, 2023- by Steven E. Greer, MD A new medical meeting poster shows the results of a double blind, randomized, controlled trial of ivermectin as a therapy for COVID. The drug works very well.

Posted in - Biotech, - Generics, - Pharma, Congress, Emergency medicine, FDA, Infectious disease, Internal Medicine | Leave a comment

Steven E. Greer, MD on OANN discussing virus therapies

Posted on December 24, 2023 by admin

April 16, 2020

Posted in - Biotech, - Generics, - Opinion, - Pharma, CDC, CMS, Congress, Emergency medicine, FDA, Geriatrics, Infectious disease, Internal Medicine, NIH, Pediatrics, Primary care medicine, Pulmonology, VA | Leave a comment

Did the COVID vaccines change the human genome?

Posted on December 14, 2023 by admin

May 11, 2023- by Steven E. Greer, MD I was the first person on any large media platform to warn that the COVID vaccines would be hard to sell because they worked by altering our genes. I said this on … Continue reading →

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology | Leave a comment

Joe Piscopo interviews Steven E. Greer, MD: 5-22-2020

Posted on July 1, 2023 by admin

May 22, 2020

Posted in - Biotech, - Generics, - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Pulmonology | Leave a comment

FDA CDER Director on Benlysta for lupus and adaptive clinical trials.

Posted on July 1, 2023 by admin

July 27, 2011- Janet Woodcock, MD, Director of the FDAs new drug division, CDER, discusses with Steven Greer,

Posted in - Biotech, - Pharma, FDA, Rheumatology | Leave a comment

WABC radio morning show Bernie & Sid interviews Steven E. Greer, MD: May 21, 2020

Posted on May 31, 2023 by admin

May 21, 2020- by Steven E. Greer, MD In this segment,

Posted in - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Internal Medicine, Pulmonology | Leave a comment